Literature DB >> 15358346

Overexpression of human transforming growth factor-beta1 using a recombinant CHO cell expression system.

Zhongcheng Zou1, Peter D Sun.   

Abstract

Transforming growth factor-beta1 (TGF-beta1) is secreted by most cells as a high molecular weight latent complex, which consists of latent TGF-beta1 disulfide bonded to latent TGF-beta1-binding protein (LTBP). Current recombinant expression systems yield less than 1-2 mg of the mature TGF-beta1 per liter of cell culture medium. In an effort to produce large quantities of the recombinant cytokine for structural studies, we have constructed a mammalian expression system based on a modified pcDNA3.1(+) vector with a glutamine synthetase gene inserted for gene amplification. The leader peptide of TGF-beta1 was replaced with that of rat serum albumin, and an eight-histidine tag was inserted immediately after the leader sequence to facilitate protein purification. In addition, Cys 33 of TGF-beta1, which forms a disulfide bond with LTBP, was replaced by a serine residue. The resulting expression construct produced a stable clone expressing 30 mg of mature TGF-beta1 per liter of spent medium. Purified TGF-beta1 bound with high affinity to its type II receptor with a solution dissociation constant of approximately 70 nM, and was fully active in both a Mv1Lu cell growth inhibition assay and in a PAI-1 luciferase reporter assay. Owing to similarities in the synthesis, secretion, and structure of TGF-beta family members, this recombinant expression system may also be applied to the overexpression of other TGF-beta isomers and even to members of the TGF-beta superfamily to facilitate their preparation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358346     DOI: 10.1016/j.pep.2003.06.001

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  21 in total

1.  Latent TGF-β structure and activation.

Authors:  Minlong Shi; Jianghai Zhu; Rui Wang; Xing Chen; Lizhi Mi; Thomas Walz; Timothy A Springer
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

2.  Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity.

Authors:  Erich J Goebel; Richard A Corpina; Cynthia S Hinck; Magdalena Czepnik; Roselyne Castonguay; Rosa Grenha; Angela Boisvert; Gabriella Miklossy; Paul T Fullerton; Martin M Matzuk; Vincent J Idone; Aris N Economides; Ravindra Kumar; Andrew P Hinck; Thomas B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-17       Impact factor: 11.205

3.  IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.

Authors:  Duncheng Wang; Debjani Ghosh; S M Touhidul Islam; Cody D Moorman; Ashton E Thomason; Daniel S Wilkinson; Mark D Mannie
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

4.  Over-expression of a human CD62L ecto-domain and a potential role of RNA pseudoknot structures in recombinant protein expression.

Authors:  Matthew Spencer; Nathan Max; Joanna Ireland; Zhongcheng Zou; Ruipeng Wang; Peter Sun
Journal:  Protein Expr Purif       Date:  2017-08-24       Impact factor: 1.650

5.  Engineering fibrin-binding TGF-β1 for sustained signaling and contractile function of MSC based vascular constructs.

Authors:  Mao-Shih Liang; Stelios T Andreadis
Journal:  Biomaterials       Date:  2011-08-23       Impact factor: 12.479

6.  Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.

Authors:  Sergei Radaev; Zhongcheng Zou; Tao Huang; Eileen M Lafer; Andrew P Hinck; Peter D Sun
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

7.  New strategy for high-level expression and purification of biologically active monomeric TGF-β1/C77S in Escherichia coli.

Authors:  Yana V Kim; Marine E Gasparian; Eduard V Bocharov; Rita V Chertkova; Elena N Tkach; Dmitry A Dolgikh; Mikhail P Kirpichnikov
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

8.  An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling.

Authors:  Sun Kyung Kim; Lindsey Barron; Cynthia S Hinck; Elyse M Petrunak; Kristin E Cano; Avinash Thangirala; Brian Iskra; Molly Brothers; Machell Vonberg; Belinda Leal; Blair Richter; Ravindra Kodali; Alexander B Taylor; Shoucheng Du; Christopher O Barnes; Traian Sulea; Guillermo Calero; P John Hart; Matthew J Hart; Borries Demeler; Andrew P Hinck
Journal:  J Biol Chem       Date:  2017-02-22       Impact factor: 5.157

9.  An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance.

Authors:  D Pépin; M Hoang; F Nicolaou; K Hendren; L A Benedict; A Al-Moujahed; A Sosulski; A Marmalidou; D Vavvas; P K Donahoe
Journal:  Technology       Date:  2013-09

10.  Development of an improved mammalian overexpression method for human CD62L.

Authors:  Haley A Brown; Gwynne Roth; Genevieve Holzapfel; Sarek Shen; Kate Rahbari; Joanna Ireland; Zhongcheng Zou; Peter D Sun
Journal:  Protein Expr Purif       Date:  2014-10-05       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.